Tag: vaccination alternatives
-
Monoclonal Antibodies Shield Infants from RSV: A New Era of Protection
Understanding RSV and the Vulnerable Population Respiratory syncytial virus (RSV) is a common winter respiratory infection that typically presents as a cold-like illness in healthy individuals. Yet, for young infants—especially those under six months—the elderly, and children with certain health conditions, RSV can lead to serious complications requiring hospitalization. In recent years, scientists and clinicians…
-
Monoclonal Antibody nirsevimab Beyfortus Shields Children from RSV
New Evidence Supports nirsevimab Beyfortus in RSV Prevention A comprehensive real-world study published in the Journal of Infection highlights the protective role of the long-acting monoclonal antibody nirsevimab, marketed as Beyfortus, against respiratory syncytial virus (RSV) in children. The findings add to the growing body of evidence that this preventive treatment can reduce RSV infections…